Navigation Links
ViroPharma Announces Presentation of Data from Non-Toxigenic Clostridium difficile (VP20621) Phase 1 Study
Date:9/15/2010

nerally well tolerated at all dose levels; there were no serious or severe adverse events, and no discontinuations from study drug due to adverse events.
  • All 27 volunteers (100 percent) who were given VP20621 had positive non-toxigenic C. difficile stool cultures by day 6, suggesting that VP20621 rapidly colonizes the susceptible GI tract.
  • No patient dosed with VP20621 tested positive for toxin-producing strains of C. difficile during the 28-day study period.
  • By comparison, 5 of 9 subjects (56 percent) who received placebo (i.e. did not receive VP20621) tested positive for either toxin-negative or toxin-positive C. difficile during the study period.

  • "I am highly encouraged by the data from this Phase 1 study of VP20621, which for the first time support the tolerability and colonization effectiveness of non-toxigenic C. difficile, mimicking what we have inferred from observing colonization of patients with these organisms," commented Dale Gerding, M.D., Associate Chief of Staff for Research at the Hines VA Hospital.  "Colonization protection of VP20621 awaits demonstration in a Phase 2 clinical trial in CDI patients to confirm pre-clinical data and observational studies of natural colonization in humans that have demonstrated high levels of protection against CDI that approach 100%."

    "Previous animal and clinical observational studies have described the prevention of symptomatic CDI by colonization of the large bowel with non-toxin producing strains of C. difficile," commented Dr. Colin Broom, ViroPharma's chief scientific officer.  "We now know that VP20621 appears to behave similarly, rapidly colonizing the large bowel and potentially protecting it from colonization with dangerous toxin-producing strains of C. difficile. We are excited by these positive data and expect to move rapidly into Phase 2 studies with VP20621 in the coming months
    '/>"/>

    SOURCE ViroPharma Incorporated
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. ViroPharma to Present at Three Upcoming Healthcare Conferences
    2. ViroPharma to Present at the Natixis Bleichroeder Conference
    3. ViroPharma To Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
    4. ViroPharma to Release 2008 First Quarter Financial Results on April 30, 2008
    5. ViroPharma Announces Discontinuation of HCV-796 Development
    6. ViroPharma Announces Completion of Enrollment in Phase 3 Study of Maribavir in Stem Cell Transplant Patients
    7. ViroPharma Incorporated Completes Acquisition of Lev Pharmaceuticals
    8. ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema
    9. ViroPharma Announces Discontinuation of Maribavir Phase 3 Study in Liver Transplant Patients
    10. ViroPharma Submits Comments on Vancocin(R) Draft Bioequivalence Guidance
    11. ViroPharma Incorporated Reports Third Quarter 2009 Financial Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/2/2015)... --  BioLife Solutions , Inc. (NASDAQ: BLFS ... clinical grade hypothermic storage and cryopreservation ... for cells and tissues  ("BioLife" or the "Company"), ... Company its 2015 Silver Awardee for Achievement in Medical ... Michael Romoser described the environment for the awards ...
    (Date:3/2/2015)... , Abbott Diabetes Care, American Association of ... Apple, Arkray, Asante Solutions, A. Menarini, Bayer ... Carewell Biotech, Centres for Medicare and Medicaid ... for Disease Control and Prevention (CDC), Carlyle ... Chugai, Conceptus, Covidien, Cygnus, ConvaTec, Constitution Medical ...
    (Date:3/1/2015)...  An innovative interventional radiology treatment has been ... of their headaches, according to research being presented ... Annual Scientific Meeting . Clinicians at Albany ... Empire State College in Saratoga Springs used a ... to give patients enough ongoing relief that they ...
    Breaking Medicine Technology:BioLife Solutions Wins Washington State 2015 Silver Award for Achievement in Medical Technology from Seattle Business Magazine 2BioLife Solutions Wins Washington State 2015 Silver Award for Achievement in Medical Technology from Seattle Business Magazine 3Blood Glucose Meters Industry 2019 Forecasts for Global and Chinese Regions 2Image-guided treatment shown to break the migraine cycle 2Image-guided treatment shown to break the migraine cycle 3Image-guided treatment shown to break the migraine cycle 4
    ... Feb. 7, 2011 Cancer ... served by just 11 modern radiotherapy linear accelerators, now ... Systems (NYSE: VAR). Treatments using fast and efficient RapidArc® ... Clinac® iX medical linear accelerator at the new United ...
    ... (NYSE: WPI ), a leading specialty pharmaceutical company, ... quarter 2010 financial results on Tuesday, February 15, 2011 prior ... will also host a conference call and webcast at 8:30 ... financial results and provide an update on the Company,s outlook ...
    Cached Medicine Technology:Cancer Patients in Bangladesh Gain Access to Advanced RapidArc Radiotherapy Treatments from Varian Medical Systems 2Cancer Patients in Bangladesh Gain Access to Advanced RapidArc Radiotherapy Treatments from Varian Medical Systems 3Watson to Host Conference Call and Webcast to Discuss Fourth Quarter 2010 Earnings 2
    (Date:3/2/2015)... A true renaissance man—some might call him a ... rock band Khazad Doom, has long inspired his countless fans. ... all odds. His motto throughout his life has always been ... was before him. And that attitude, born amidst the turmoil ... to a new generation. , As Eadon knows, when you ...
    (Date:3/2/2015)... 2015 ProvidaStaff has announced ... educational healthcare division to EDU Healthcare to ... to school systems and students nationwide. , “ProvidaStaff has ... districts throughout the country,” said Angela M. Lewis, President ... better organization and the introduction of EDU Healthcare better ...
    (Date:3/1/2015)... 02, 2015 Security Life Insurance ... benefits market, announced the addition of stand-alone individual ... Vision Insurance launched today, complete with two plan ... utilize the VSP® Vision Care network encompassing a ... practice space. The PrimeStar Select Vision plan will ...
    (Date:3/1/2015)... NY (PRWEB) March 01, 2015 Adults ... seek insurance rates for term or universal policies can ... some of the best life insurance companies for single ... the system at http://quotespros.com/life-insurance.html . , The rate ... search portal are tied to a number of life ...
    (Date:3/1/2015)... Indiana Fiber Network, LLC (IFN), the ... Networking, LLC (NewWays) selected IFN as primary fiber ... is well positioned to scale future backbone transport ... in rural parts of Indiana,” said Scott Reed, ... IFN Enterprise Sales Manager, IFN provides NewWays fiber ...
    Breaking Medicine News(10 mins):Health News:Cult Rock Star’s “Got To Make It” Attitude Inspires New Generations 2Health News:Cult Rock Star’s “Got To Make It” Attitude Inspires New Generations 3Health News:ProvidaStaff Announces New Name Change to EDU Healthcare for Its Educational Healthcare Division 2Health News:ProvidaStaff Announces New Name Change to EDU Healthcare for Its Educational Healthcare Division 3Health News:Security Life Insurance Company Launches Individual Vision Insurance Product 2Health News:Best Life Insurance Companies for Single Adults Now Searchable at Insurance Website 2Health News:NewWays Networking Selects Indiana Fiber Network, LLC as Fiber Transport Provider 2
    ... Call System scheduled to start this month.BERKELEY HEIGHTS, ... venture formed by Authentidate Holding Corp. (Nasdaq: ... Sheets: ECSL) to provide remote patient monitoring telehealth ... with chronic conditions announced today that its remote ...
    ... Dr. John Abramson and health care ethics expert Dr. ... care professionalsCHICAGO, April 14 The Midwest Business Group ... speakers and agenda for the third annual Pharmacy Benefits ... O,Hare in Chicago, August 4-5, 2009. The program provides ...
    ... Mass., April 14 Alseres Pharmaceuticals, Inc. (Nasdaq: ... it received a NASDAQ Staff Determination indicating that the ... million market value of listed securities requirement set forth ... accordingly, the Company,s common stock will be delisted from ...
    ... Schwarzenegger,s Allied Health Initiative to Train Thousands of ... Ensure Continuation of Medical ServicesFOUNTAIN VALLEY and LONG ... shortages plaguing the state,s hospitals and health care ... will go a long way in training thousands ...
    ... longer survival, study concludes , , TUESDAY, April 14 ... advanced lung cancer can survive longer when treated ... study by the University of Michigan Comprehensive Cancer ... cell lung cancer survived, on average, almost 16 ...
    ... Researchers at Amgen are testing a fully human monoclonal ... (IGF-1 and IGF-2) and appears to reduce pancreatic cancer ... Molecular Cancer Therapeutics , a journal of the ... one of the deadliest cancers, and less than 4 ...
    Cached Medicine News:Health News:ExpressMD(TM) Solutions' Remote Patient Health Monitoring Device Receives 510(K) Market Clearance Approval From FDA 2Health News:ExpressMD(TM) Solutions' Remote Patient Health Monitoring Device Receives 510(K) Market Clearance Approval From FDA 3Health News:ExpressMD(TM) Solutions' Remote Patient Health Monitoring Device Receives 510(K) Market Clearance Approval From FDA 4Health News:ExpressMD(TM) Solutions' Remote Patient Health Monitoring Device Receives 510(K) Market Clearance Approval From FDA 5Health News:Keynote Speakers Announced for 2009 Pharmacy Benefits Academy 2Health News:Keynote Speakers Announced for 2009 Pharmacy Benefits Academy 3Health News:Alseres Pharmaceuticals, Inc. Receives Notice of De-Listing of Its Securities for Failure to Regain Compliance with Continued Listing Requirements 2Health News:Alseres Pharmaceuticals, Inc. Receives Notice of De-Listing of Its Securities for Failure to Regain Compliance with Continued Listing Requirements 3Health News:Barry Arbuckle, MemorialCare Medical Center CEO and California Hospital Association Past Chair, Speaks Out on Impact of 3-Year, $32 Million Public-Private Partnership 2Health News:Radiation-Chemo Combo Boosts Lung Cancer Outcomes 2
    ... yet, provides functional support for patients engaged ... design feels lighter than air, while its ... and contraction for superior comfort during extended ... MCL, LCL, PCL, rotary and combined instabilities ...
    ... Defiance III is DonJoy's hallmark knee brace. ... design, this lightweight brace provides durable support ... and LCL instabilities. Plus, the low-profile design ... including hockey and football. As the strongest ...
    Provides rigid support and immobilization for the knee...
    The Bledsoe Ultimate CI is a sport functional knee brace designed for instabilities of combined ACL and PCL injured knees. Additional knee injuries to the medial collateral ligament along with the cr...
    Medicine Products: